Valuation: Terumo Corporation

Market Cap 3,286B 20.2B 17.72B 16.36B 15.12B 28.65B 1,934B 29.22B 197B 76.4B 947B 75.86B 74.19B P/E 2027 *
19.7x
P/E 2028 * 17.7x
Enterprise Value 3,361B 20.67B 18.13B 16.73B 15.46B 29.31B 1,979B 29.9B 201B 78.16B 968B 77.6B 75.9B EV / Sales 2027 *
2.72x
EV / Sales 2028 * 2.51x
Free-Float
97.07%
Yield 2027 *
1.6%
Yield 2028 * 1.79%
1 day-2.15%
1 week+3.29%
Current month-0.29%
1 month-2.50%
3 months+0.84%
6 months-2.37%
Current year-1.87%
1 week 2,215
Extreme 2215
2,364.5
1 month 2,146.5
Extreme 2146.5
2,364.5
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 75 25/06/2020
Director/Board Member 63 21/06/2019
Chairman 68 01/04/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.15%+3.29%-9.38%+3.10% 20.64B
-0.83%-1.09%-29.17%-11.83% 166B
+0.70%-0.60%-7.09%-4.35% 105B
-2.25%+2.42%+1.18%+57.50% 60.23B
+3.64%-4.34%+45.42%+51.88% 49.17B
+0.01%-4.56%-14.04%-41.43% 41.49B
+1.22%-5.30% - - 34.08B
-2.55%+1.24%-15.01%-44.78% 28.58B
+0.67%-2.60%+57.50%-5.58% 24.99B
+1.81%-2.15%-7.69%-4.28% 20.42B
Average +0.04%+1.27%+2.41%+0.03% 55.04B
Weighted average by Cap. -0.06%+1.99%-6.20%+0.84%

Financials

2027 *2028 *
Net sales 1,236B 7.6B 6.67B 6.16B 5.69B 10.78B 728B 11B 74B 28.75B 356B 28.55B 27.92B 1,315B 8.08B 7.09B 6.55B 6.05B 11.47B 774B 11.7B 78.7B 30.58B 379B 30.36B 29.7B
Net income 166B 1.02B 893M 824M 761M 1.44B 97.43B 1.47B 9.91B 3.85B 47.68B 3.82B 3.74B 185B 1.14B 999M 922M 852M 1.61B 109B 1.65B 11.08B 4.31B 53.35B 4.28B 4.18B
Net Debt 75.69B 465M 408M 377M 348M 660M 44.55B 673M 4.53B 1.76B 21.8B 1.75B 1.71B 14.29B 87.85M 77.06M 71.14M 65.74M 125M 8.41B 127M 855M 332M 4.12B 330M 323M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
09/07/26 ¥2,227.50 -2.15% 3,400,200
08/07/26 ¥2,276.50 -2.04% 5,188,900
07/07/26 ¥2,324.00 +1.33% 4,707,100
06/07/26 ¥2,293.50 +1.57% 2,726,200
03/07/26 ¥2,258.00 +1.96% 5,994,400
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,276.50JPY
Average target price
2,961.54JPY
Spread / Average Target
+30.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock